Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL2105738 (Galeterone, TOK 001, TOK-001, VN 124, VN-124, VN/124, VN/124-1) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
Androgen receptor/Androgen Receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1871] [GtoPdb: 628] [UniProtKB: P10275] | ||||||||
GtoPdb | - | - | 6.42 | pIC50 | 384 | nM | IC50 | J Med Chem (2005) 48: 2972-84 [PMID:15828836] |
ChEMBL | Displacement of [3H]R1881 from androgen receptor in human LNCAP cells | B | 6.07 | pEC50 | 845 | nM | EC50 | J Med Chem (2015) 58: 2077-2087 [PMID:25591066] |
ChEMBL | Displacement of [3H]R1881 from AR in human LNCaP cells after 2 hrs by scintillation counting analysis | B | 6.17 | pEC50 | 670 | nM | EC50 | J Med Chem (2013) 56: 4880-4898 [PMID:23713567] |
ChEMBL | Displacement of [3H]R1881 from androgen receptor in human PC3 cells | B | 6.39 | pEC50 | 405 | nM | EC50 | J Med Chem (2015) 58: 2077-2087 [PMID:25591066] |
CYP17A1/Cytochrome P450 17A1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3522] [GtoPdb: 1361] [UniProtKB: P05093] | ||||||||
ChEMBL | Inhibition of human truncated CYP17A1 expressed in Escherichia coli | B | 6.12 | pIC50 | 752 | nM | IC50 | J Med Chem (2013) 56: 4880-4898 [PMID:23713567] |
GtoPdb | - | - | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (2005) 48: 2972-84 [PMID:15828836] |
ChEMBL | Inhibition of human CYP17 expressed in Escherichia coli | B | 6.52 | pIC50 | 300 | nM | IC50 | J Med Chem (2015) 58: 2077-2087 [PMID:25591066] |
ChEMBL | Inhibition of human membrane bound C-terminal His4-tagged CYP17A1 delta19H mutant assessed as reduction in progesterone hydroxylation preincubated for 3 mins followed by NADPH addition measured after 10 mins in presence of NADPH-cytochrome p450 reductase by HPLC method | B | 6.55 | pIC50 | 282 | nM | IC50 | US-20160031929-A1. Inhibitors of cyp17a1 (null) |
ChEMBL | Inhibition of CYP17 (unknown origin) | B | 6.85 | pIC50 | 140 | nM | IC50 | ACS Med Chem Lett (2016) 7: 708-713 [PMID:27437082] |
ChEMBL | Inhibition of C-terminal His-tagged recombinant human CYP17A1delta19H mutant expressed in Escherichia coli DH5alpha assessed as decrease in progesterone hydroxylation preincubated for 3 mins followed by NADPH addition measured after 10 mins in presence of cytochrome p450 reductase by LC-MS/MS method | B | 7.55 | pIC50 | 28.1 | nM | IC50 | J Med Chem (2018) 61: 4946-4960 [PMID:29792703] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]